References
- Azerad R. Microbial models for drug metabolism. Adv Biochem Eng Biotechnol 1999; 63: 169–218
- Azerad R, Biton J, Lacroix I. 1999. Nouveau procédé de préparation de la fexofénadine. Patent WO 99/47693.
- Di Giacomo B, Coletta D, Natalini B, Ni M-H, Pellicciari R. A new synthesis of carboxyterfenadine (fexofenadine) and its bioisosteric tetrazole analogs. IL Farmaco 1999; 54: 600–610
- Fang QK, Senanayake CH, Wilkinson HS, Wald SA, Li H. An efficient and facile synthesis of racemic and optically active fexofenadine. Tetrahedr Letts 1998; 39: 2701–2704
- Guengerich FP. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 2001; 14(6)611–650
- Jezquel SG. Microbial models of mammalian metabolism: Uses and misuses (clarification of some misconceptions). J Mol Cat B: Enzym 1998; 5: 371–377
- Jurima-Romet M, Crawford K, Cyr T, Inaba T. Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals. Drug Metab Dispos 1994; 22(6)849–857
- Kawai SH, Hambalek RJ, Just G. A facile synthesis of an oxidation product of terfenadine. J Org Chem 1994; 59: 2620–2622
- Markham A, Wagstaff A. Fexofenadine. Drugs 1998; 55(2)269–274
- Mazier C, Jaouen M, Sari M-A, Buisson D. Microbial oxidation of terfenadine and ebastine into fexofenadine and carebastine. Bioorg Med Chem Letts 2004; 14(21)5423–5426
- Meiwes J, Worm M. 1998. Process for the preparation of 4-(4-(4-(hydroxybiphenyl)-1-piperidinyl)-1-hydroxybutyl)-α,α-dimethylphenyl-acetic acid and phosphorylated derivatives. EP 864653.
- Michels PC, Zirbes EL. 2002. Process for the production of piperidine derivatives with microorganisms. US Patent 2002/0087003.
- Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LRJ. Torsades de pointes occurring in association with terfenadine use. JAMA 1991; 266: 2375–2376
- Pacey MS. 2003. US Patent 6,610,518 B2.
- Patel S, Waykole L, Repic O, Chen K-M. Synthesis of terfenadine carboxylate. Synth Commun 1996; 26(24)4699–4710
- Pohjola-Sintonen S, Viitasalo M, Toivonen L. Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia. Eur J Clin Pharmacol 1993; 45: 191–193
- Rafferty P, Holgate ST. Terfenadine (Seldane) is a potent and selective histamine H1 receptor antagonist in asthmatic airways. Am Rev Respir Dis 1987; 135(1)181–184
- Renwick AG. The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes. Clin Exp Allergy: J Br Soc Allergy Clin Immunol 1999; 29: 116–124
- Sariaslani FS, Kunz DA. Induction of cytochrome P-450 in Streptomyces griseus by soybean flour. Biochem Biophys Res Commun 1986; 141(2)405–410
- Schmitz G, Franke D, Stevens S, Takors R, Weuster-Botz D, Wandrey C. Regioselective oxidation of terfenadine with Cunninghamella blakesleena. J Mol Cat B: Enzym 2000; 10: 313–324
- Schwartz H, Böttcher H. 1993. Process for the preparation of carebastine and similar materials. US Patent 5,204,249.
- Schwartz H, Licht RE, Radunz HE. Microbial metabolism of the beta-adrenoreceptor antagonist Bisoprolol. Appl Microbiol Biotechnol 1993; 40(2–3)382–385
- Schwartz H, Liebig-Weber A, Hochstätter H, Böttcher H. Microbial oxidation of ebastine. Appl Microbiol Biotechnol 1996; 44: 731–735
- Simpson K, Jarvis B. Fexofenadine: A review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs 2000; 59(2)301–321
- Smith RV, Rosazza JP. Microbial models of mammalian metabolism. J Pharm Sci 1975a; 64(11)1737–1759
- Smith RV, Rosazza JP. 1975b. Microbial systems for study of the biotransformations of drugs. Biotechnol Bioeng XVII:785–814.
- Trower MK, Sariaslani FS, O'Keefe DP. Purification and characterization of a soybean flour-induced cytochrome P-450 from Streptomyces griseus. J Bacteriol 1989; 171(4)1781–1787